LLM-Assisted Structural Analysis of Vault-Like Particles: Candidate Screening, Expression, and Cryo-EM Reconstruction

1. Study Object: Vault-Like Particles Are Not Native Prokaryotic Vaults

This article focuses on protein shells formed by phage-derived candidate proteins that self-assemble in Escherichia coli. These structures are called vault-like particles. They are not complete, naturally occurring Vaults found in prokaryotes, nor are they direct substitutes for native eukaryotic Vaults. Instead, they are closer to an engineered, experimentally accessible simplified model that can be used to assess whether candidate proteins have self-assembly capability. AI-assisted cryo-EM, structural biology large models, and three-dimensional reconstruction workflows can then be used to analyze their structures.

To avoid conceptual confusion, the related objects can be distinguished as follows:

Object	Source	Assembly environment	Structural characteristics	Citation caution
Eukaryotic native Vault	Eukaryotes	Native cellular environment	Large, hollow, complex protein assembly	Cannot be directly equated with the subject of this case
Prokaryote-related candidate shells	Homologous sequences or candidate proteins of prokaryotic origin	Native or recombinant systems	Requires experimental validation	Sequence, copy number, and structural evidence should be verified
E. coli vault-like particles	Phage-derived candidate proteins	Recombinant expression in E. coli	Engineered shells formed by self-assembly	Experimental model only; not equivalent to native Vault

Therefore, formal writing or citation should specify “vault-like shell structures expressed in an E. coli system” and avoid directly equating them with native Vaults or native prokaryotic homologs. When information about copy number, subunit arrangement, internal cavity, assembly pathway, and host environment is discussed, the original structural model, database record, or experimental method source should be provided.

2. Key Terms for Readers Less Familiar with Structural Biology

To make the following workflow easier to understand, a few key terms are explained first:

• Bacteriophage, or phage: A virus that infects bacteria. Its proteins can often be expressed in bacterial hosts and are suitable for rapid screening and experimental validation.
• Candidate protein: A protein initially selected from a large sequence set as potentially having the target structure or function. It still requires experimental confirmation.
• Expression and purification: Producing the target protein in host cells and obtaining a relatively pure sample through chromatography, centrifugation, concentration, and related methods.
• Cryo-electron microscopy, or cryo-EM: A technique that uses vitrified specimens to observe biomolecular complexes in a state close to their native condition.
• Three-dimensional reconstruction: Reconstructing a three-dimensional density map from a large number of two-dimensional projection images using algorithms.
• Resolution: A metric describing the level of detail in a three-dimensional structure. Usually, a smaller value indicates a clearer structure.
• Copy number: The number of identical protein subunits in a complex. It needs to be judged using symmetry, structural models, and counting methods together.

3. LLM-Assisted Candidate Protein Screening: From Large Sequence Sets to an Experimental Shortlist

In structural biology projects, large language models can help organize, filter, and rank very large sets of predicted protein sequences. Researchers usually do not ask the model to directly “guess the correct protein.” Instead, they use the model to group, score, and prioritize candidate proteins based on evolutionary relationships, domain features, molecular weight ranges, transmembrane risk, expression feasibility, and historical experimental records.

1. Minimum Practical Input Fields

At a minimum, the candidate screening stage should include the following fields:

• Sequence ID, species source, and protein length;
• Domain prediction results, such as Vault-like domains, MVP-like domains, or other shell-related motifs;
• Domain confidence scores;
• Number and positions of transmembrane segments;
• Low-complexity regions, disordered regions, and aggregation risk;
• Predicted molecular weight, isoelectric point, and hydrophobicity;
• Host compatibility, including GC content, codon preference, toxicity risk, and plasmid compatibility;
• Historical expression records, purification difficulty, and cryo-EM sample preparation risk;
• Model or retrieval system version, run date, and parameter file version.

2. Example CSV Header for Candidate Screening

To make implementation easier, candidate screening results can be output as a structured table. An example CSV header is as follows:

candidate_id,source_taxon,length,domain_call,domain_score,tm_count,disorder_ratio,aggregation_risk,host_compatibility,priority,review_id,model_version,evidence_level

In this table, review_id is used to record human review, model_version is used to record the version of the model or retrieval system, and evidence_level indicates whether the candidate has experimental data, public structural data, or only comes from prediction.

3. Example Scorecard and Thresholds

The thresholds below are examples. In a real project, they should be calibrated according to the target complex, host system, and experimental history:

Metric	Acceptable direction	Risk flag	Suggested action
Domain confidence	Higher	Low confidence or missing domain	Lower priority; manually check domain boundaries
Number of transmembrane segments	Fewer	Multiple strong transmembrane predictions	Flag membrane-protein-like risk; adjust expression conditions
Disordered region ratio	Lower	Excessively high disorder ratio	Flag flexibility or sample-preparation risk
Aggregation risk	Low to medium	High aggregation risk	Prioritize small-scale expression and solubility testing
Host compatibility	Compatible with target host	Codon, toxicity, or plasmid conflicts	Redesign the vector or change the host
Structural relevance	Clear relation to known shells	No reliable homology or structural evidence	Lower priority; supplement evidence

4. Human Review Points

Model output can only serve as a priority reference. Researchers should review at least the following:

• Whether the predicted domains truly exist, rather than being false positives caused by low-complexity regions;
• Whether transmembrane predictions are reliable, or are merely hydrophobic fragments;
• Whether the candidate protein has sufficient evidence to support its participation in shell assembly;
• Whether the expression host, vector, and induction conditions match the target;
• Whether the experimental budget, timeline, and equipment conditions allow validation of the candidate;
• Whether all high-priority candidates have experimental IDs and review conclusions recorded.

5. Failure-Case Notes

Even when the model gives a high ranking, a candidate protein may still fail. For example, some candidates may have toxicity so strong that host bacterial growth is limited; some may enter inclusion bodies because of hydrophobic exposure; some may score well by sequence but produce heterogeneous particles after purification; and some may have tags that interfere with self-assembly, preventing cryo-EM samples from forming the target structure. Therefore, model output should be treated as an experimental priority reference, not as a final conclusion.

4. Expression, Purification, and Sample QC: Turning Model Suggestions into Experimental Records

After candidate proteins are determined, the expression vector, induction temperature, expression time, lysis method, buffer formulation, affinity tag, chromatography order, and concentration conditions may all affect the final quality of structural analysis. Large language models can generate multiple alternative plans based on existing experimental records, public protocols, and historical project data.

1. Experimental Design Support from Large Language Models

The model can suggest:

• Using expression vectors with different strengths or copy numbers;
• Flagging that certain tags may interfere with complex assembly;
• Lowering the induction temperature to reduce inclusion body formation;
• Noting that salt concentration, pH, or reducing agents in the buffer may affect particle stability;
• Performing small-scale expression and solubility testing before large-scale purification;
• Recording the expression level, solubility fraction, purity, and particle state for each batch.

2. Purification Efficiency Claims Require Conditions

Case-style articles often mention that “the purification workflow was significantly shortened.” If such a statement is cited, the corresponding conditions must be added, including:

• Which step or stage was shortened;
• Whether the sample type was a soluble complex;
• The host strain and expression vector used;
• The purification equipment and chromatography column type;
• The buffer system and flow rate;
• The number of replicates and success rate;
• Whether negative-stain EM or dynamic light scattering confirmed sample quality.

If these conditions cannot be provided, relative wording should be used instead, such as “when the sample is stable and the workflow is mature, the purification process may be optimized,” rather than giving a single time metric.

3. Sample QC Checklist

Sample quality control is an area where large language models can assist. The model can help organize results from negative-stain EM, dynamic light scattering, SEC-MALS, SDS-PAGE, and similar methods, and can flag anomalies such as particle aggregation, insufficient sample concentration, prominent degradation bands, or asymmetric elution peaks. Recommended QC records include:

• Whether the target particles show the expected morphology;
• Whether the particles are homogeneous;
• Whether obvious aggregation, fragments, or degradation are present;
• Whether the sample concentration and buffer system are suitable for cryo-EM grid preparation;
• Whether records of sample batch, freeze-thaw cycles, and storage conditions are retained.

The final judgment should still be made by experimental personnel.

5. Cryo-EM Data Processing and Three-Dimensional Reconstruction: Defining Acceptance Criteria

Cryo-EM is an important tool for analyzing large protein complexes. Its basic workflow includes sample preparation, vitrification, data collection, two-dimensional classification, three-dimensional classification, three-dimensional reconstruction, resolution assessment, model building, and validation. For large shell proteins, issues such as symmetry, local flexibility, preferred orientation, and particle heterogeneity also need to be addressed.

In this type of study, researchers can express candidate proteins in E. coli and use cryo-EM to analyze their three-dimensional structures. When copy number, total molecular weight, subunit arrangement, and symmetry are discussed, structural data sources should be provided, such as PDB entries, EMDB entries, raw density maps, symmetry settings, subunit counting methods, and resolution metrics. If these cannot be verified, qualitative descriptions should be used instead, and specific unconfirmed values should be avoided.

1. Model-Supported Processing Tasks

Large language models can participate in the following auxiliary work:

• Organizing cryo-EM data processing parameters, such as pixel size, total dose, particle count, symmetry, and mask radius;
• Drafting structural validation reports;
• Flagging abnormal regions, such as insufficient local density, abnormal subunit repeats, symmetry conflicts, or density breaks;
• Highlighting regions that require manual review, especially contact interfaces, cavity boundaries, and low-density flexible regions.

2. Acceptance Metrics for a Structural Validation Report

A draft structural validation report should not only say that “the resolution is acceptable.” It should include reviewable metrics:

• The overall resolution assessment method, such as Fourier Shell Correlation, often using FSC 0.143 as the reference standard;
• Local resolution assessment results, indicating whether high-flexibility regions or interface regions show decreased resolution;
• Model-to-density fit metrics;
• Geometry and stereochemistry sanity checks;
• Q-score, EMRinger, or similar metrics used to evaluate local agreement between the model and density;
• Whether the symmetry and copy-number settings are consistent;
• Whether over-averaging occurred or whether local flexibility was incorrectly modeled;
• Whether the final model passed human review.

3. Human Review Focus

Cryo-EM results cannot be generated solely through automated workflows. Models can help the team locate problems faster, but they cannot replace the judgment of structural biology experts. Human review should focus on:

• Whether the density map provides sufficient evidence to support the current model;
• Whether the subunit interfaces are reasonable;
• Whether the symmetry settings are consistent with the properties of the sample;
• Whether local flexible regions were forcibly modeled;
• Whether the model meets chemical reasonableness and biological consistency requirements;
• Whether the data support the reproducibility of the conclusions.

6. Stage-by-Stage View of AI Participation in Research

Stage	LLM input	Output	Human judgment	Risk points	Acceptance criteria
Candidate protein screening	Sequences, domains, transmembrane risk, expression records	Candidate list, priorities, risk labels	Review false positives and experimental feasibility	Data bias, domain misjudgment	Candidates have an experimental validation path
Expression protocol design	Vectors, hosts, induction conditions, historical data	Expression condition suggestions	Choose an executable plan	Toxicity, inclusion bodies, degradation	Soluble expression meets experimental requirements
Purification workflow design	Protein properties, buffers, chromatography strategy	Purification step suggestions	Assess sample stability	Particle disruption, aggregation	Sample homogeneity meets grid-preparation requirements
Cryo-EM data collection	Instrument parameters, sample concentration, grid information	Parameter organization, anomaly flags	Review acquisition quality	Preferred orientation, ice-layer anomalies	Data volume meets reconstruction requirements
Three-dimensional reconstruction	Classification results, density maps, symmetry settings	Parameter suggestions, anomaly flags	Verify structural reasonableness	Wrong symmetry, over-averaging	Resolution and model quality meet standards
Structural modeling	Density maps, sequences, chemical constraints	Initial model, validation report	Manual correction and final review	Geometric issues, interface errors	Pass validation and human review

7. Conditions Under Which Efficiency Gains Apply

Case studies often include statements such as “model building was significantly accelerated.” These statements need to specify their applicable conditions to avoid giving readers the impression that AI can instantly accelerate research at every stage.

First, model-building speed usually corresponds only to a specific stage, such as modeling, parameter organization, or anomaly identification. It does not equal completion of the entire process from sequence screening to structural analysis. Second, that speed may depend on high-quality samples, a mature cryo-EM workflow, a stable computational environment, and an experienced team. Third, real research often requires repeated experiments, multiple rounds of optimization, and anomaly troubleshooting. Failure rates can affect the actual timeline.

When citing efficiency gains, it is recommended to record:

• Sample type and expression stability;
• Whether the candidate proteins have been confirmed to assemble;
• The status and automation level of the cryo-EM equipment;
• Data processing software, computational resources, and parameter standards;
• The team’s familiarity with structural biology;
• The number of experimental replicates and failure rate;
• Whether prior candidate screening and method validation have been completed.

In other words, large language models do not provide instantaneous acceleration of a single step. Rather, when experimental design, sample preparation, data collection, and computational analysis form a closed loop, the overall research pace may improve.

8. Risk Boundaries and Compliance Checklist

Large language models participating in research must be subject to experimental validation. The following checklist can be used for internal project review:

• All model-generated candidate rankings, protocol suggestions, and parameter prompts must be linked to experimental record IDs.
• Sequence similarity cannot replace structural validation. Candidate proteins must be confirmed through expression, purification, imaging, and structural reconstruction.
• Data bias must be recorded, including reference database coverage, species bias, sequence sampling time, and model training data limitations.
• Cryo-EM structural models must pass checks for resolution, local resolution, geometric reasonableness, chemical constraints, and biological consistency.
• If the model flags abnormal copy number, missing density, or symmetry conflicts, human review records should be retained.
• Biosafety must meet experimental requirements. Expression vectors and plasmids need approval, host strains and biological materials should have clear risk levels, and related operations should be completed under the corresponding biosafety level.
• When viral-derived sequences, bacterial expression, and protein samples are involved, laboratory biosafety rules should be followed, and waste should be inactivated or disposed of in compliance with requirements.
• Experimental samples should use unified codes to avoid sample identity confusion. Key samples should retain source, processing batch, and freeze-thaw records.
• Data access should be tiered. Unpublished sequences, unpublished structural models, and raw experimental data should not be uploaded arbitrarily to external models.
• The system should record model version, prompt version, input data version, and output results to ensure traceability.
• Anomalous events should be reported, including sample contamination, expression failure, cryo-grid preparation anomalies, data acquisition anomalies, and obvious deviations in model output.

A reasonable positioning is: large language models are amplifiers of the research workflow, not publishers of research conclusions.

9. Engineering Implementation: Building a Data–Design–Experiment–Analysis Loop

If a research team wants to introduce similar capabilities, it is recommended to start with process building rather than pursuing only a single-point tool. An operable closed loop includes sequence data preparation, preliminary screening and ranking of candidate proteins, expression and purification protocol design, experimental execution and sample quality control, cryo-EM data acquisition, three-dimensional reconstruction, result validation, and iterative optimization.

In engineering implementation, the following foundational capabilities need to be supported:

• Object storage: Save raw sequences, experimental records, microscopy images, density maps, and intermediate results;
• Compute resource pool: Support large-scale sequence retrieval, image classification, three-dimensional reconstruction, and model validation;
• Task scheduling system: Manage expression, purification, imaging, computation, and review tasks;
• Logging, monitoring, and alerting: Record experimental parameters, computational task status, and anomalous events;
• Data version management: Ensure that changes in models, parameters, images, and results are traceable;
• Experimental template library: Standardize candidate protein physicochemical properties, expression hosts, purification conditions, sample preparation methods, imaging parameters, and acceptance metrics.

Standardized templates are especially important. Only when experimental fields are sufficiently standardized can the model provide suggestions within a controlled environment, rather than producing generalized output detached from experimental facts.

10. Frequently Asked Questions

1. How do large language models screen candidate proteins?
Large language models usually do not directly “guess the correct protein.” Instead, they group and rank candidates based on sequence length, domains, transmembrane risk, aggregation risk, expression suitability, and historical experimental records, helping researchers narrow the search space.

2. Can large language models directly generate the final structure?
No. They can generate initial models, parameter suggestions, or draft validation reports, but the final structure must pass density map inspection, geometric validation, chemical reasonableness checks, and human review.

3. How can sensitive sequences be prevented from being uploaded?
Unauthorized experimental samples, unpublished structural models, sensitive biological material information, raw images lacking metadata, and intermediate data involving biosafety approval should not be uploaded arbitrarily to external models. Localized or controlled-access environments should be used.

4. How should prompt versions be recorded?
Task records should store the prompt template, model version, input data version, output results, human adoption status, and subsequent experimental IDs to ensure traceability.

5. What are common errors in cryo-EM analysis?
Common errors include incorrect symmetry settings, preferred orientation causing distortion in three-dimensional reconstruction, particle heterogeneity causing classification bias, insufficient local resolution causing modeling errors, and over-averaging masking true flexible regions.

6. How can the reliability of AI suggestions be verified?
One should check experimental replicate results, independent validation data, parameter audit records, human review opinions, and structural validation metrics. No AI suggestion should be adopted based on a single output alone.

11. Conclusion

The case of vault-like particles formed by self-assembly of phage-derived candidate proteins in E. coli demonstrates a feasible path for large language models in structural biology research: narrowing the candidate range from very large sequence sets and providing collaborative support in expression, purification, sample preparation, cryo-EM data processing, and three-dimensional reconstruction. For research teams, the real value is not in chasing a single-point tool, but in building comprehensive capabilities in data governance, experimental closed loops, computational scheduling, and human-AI collaboration.